At week 60, 378 participants were randomised to continue tirzepatide MTD (N=140), reduce to tirzepatide 5mg (N=144), or switch to placebo (N=94) for a further 52 weeks
Please perform a patch test before using the product to check for any allergic reactions
As monotherapy, in a phase 2 study, cagrilintide led to significant reductions in body weight and was well-tolerated in participants with overweight or obesity [10]
PlexusDx patients receiving compounded tirzepatide from licensed 503A pharmacies report satisfaction rates consistent with branded formulations, with injection comfort improving significantly after the first 23 doses as anxiety decreases and technique improves
If the patient is tender on palpation but not painful on the single leg stance test and your assessment ends there, your conclusion would be that the patient does not have gluteal tendinopathy (false negative)
5.3 Wanting: evidence for reward motivation and craving-related endpoints Changes in liking do not necessarily imply changes in wanting (81)